Early ctDNA clearance, combined with complete response on PET-CT, correlates with prolonged progression-free survival. ctDNA testing is minimally invasive and can be conducted repeatedly, offering a ...

Newly diagnosed PTCL; Two dose regimes of golidocitinib combined with CHOP have been explored for the treatment of newly ...

A single signaling pathway controls whether immune cells attack or befriend cells they encounter while patrolling our bodies, ...

Zanubrutinib combined with R-CHOP showed high efficacy in DLBCL patients with activated BCR signaling and specific genetic mutations, achieving a 91.4% ORR and 79.3% CR rate. The study's primary ...

The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors ...

Major histocompatibility complex class II (MHC-II) molecules play a critical, yet historically overlooked, role in tumor ...

The zebrafish brain combines a conserved heterogeneity of immune cells with a unique dendritic cell-like population.

Human intestinal M cells function as dendritic cell-like antigen-presenting cells, displaying constitutive MHC-II activity ...

2025 年 6 月 12 日，北京放射医学研究所高月院士、周维教授及上海交通大学吕海涛团队、何宝坤团队在Exploration 杂志上发表了题为Gut Microbiota-Associated Metabolites Affected the ...

By manipulating this pathway, scientists may be able to tweak the immune response to treat cancers, autoimmune disorders, and more.

Kazia Therapeutics Limited ("Kazia" or the "Company")  today announced new data from two presentations at the 2025 San Antonio Breast Cancer Symposium (SABCS) providing compelling mechanistic and ...